FY20 appropriations

Dear Research Advocate, With new rumors surfacing daily, it’s difficult to gauge the odds of Congress and the Trump Administration completing FY20 appropriations this calendar year. We are now anticipating another short-term CR that will flat-fund government into December, buying a bit more time for final negotiations. If those negotiations fail, the options become yet another CR or a government shutdown. None of these scenarios serves the public interest. Imagine if federal agencies couldn’t adjust spending to jettison what is not working and invest in what is. Imagine if there were resources to seed the kind of medical and public health progress that saves lives, yet those resources lie...
Dear Research Advocate, Congress has five weeks to reach an agreement on full-year FY20 funding levels before the current stop-gap continuing resolution (CR) expires on November 21, 2019. House spending leaders sent their Senate counterparts new totals for the 12 annual appropriations bills, but word is, negotiations on those topline amounts are far from over and concerns are mounting that Congress could resort to another short-term CR. CRs are the enemy of medical and public health progress: consider the recent NIH-supported finding that the artificial pancreas system controls blood glucose levels better than current technology in patients with Type 1 diabetes or promising results in...
Dear Research Advocate, The distinguished 2019 Nobel Laureates announced this week made fundamental discoveries that have transformed the future for Americans and populations across the globe. Taxpayers, via appropriations to NIH and NSF, have long provided support to several of these and many past Nobelists, thereby ensuring that discovery builds on discovery and drives development and delivery of ever-increasing societal benefits over time. (See our statements here and here ) But what are we doing to nurture future Nobel laureates? Robust NIH and NSF support for researchers across the nation hinges on the ability of the House and Senate to negotiate final FY20 appropriations before the...
Dear Research Advocate, As part of the U.S. Chamber of Commerce’s launch of Civics Forward , CEO Thomas Donahue challenged the business community to play a leading role in civic education, for no less a reason than assuring the future of our nation. This challenge is reminiscent of his call to the science community last February at the AAAS meeting to do more with the business community, in order to achieve shared aspirations. As he said at the time, “without science there is no innovation, and without innovation, there is no industry,” going on to emphasize the enduring value the business community accords to science. There is no question that heightened attention to civic education and...
Dear Research Advocate, This week was chock-full of federal appropriations activity bearing on the future of research, and ultimately, the future of health. While agency funding for Fiscal Year 2020 is far from resolved, some very positive and not-so-positive steps were taken by Congress. First, the Senate Appropriations Committee released its long-awaited Labor/HHS bill. The exciting headline is that NIH received a vital $3 billion increase, which, if enacted, would bring its total funding to $42.08 billion. The CDC, meanwhile, would receive an increase of only $180 million for a total budget of $7.46 billion. This increase is woefully insufficient to enable CDC’s 24/7 vigilance and...
Dear Research Advocate, I’m writing early this week to remind those of you who won’t be joining us in person that you can join our National Research Forum tomorrow, Thursday, via livestream. See more information at the end of this letter. Political theater isn’t everyone’s cup of tea, but I have always enjoyed it, from the Greeks to Hamilton. A remarkable, multiple-award-winning play, “What the Constitution Means to Me” will open soon at the Kennedy Center after a successful run on Broadway, and will soon head to the West Coast. I highly recommend it. Written several years ago by Heidi Schreck, who is also the lead, the work brings out the good news – and the complicated and ever-evolving...
Dear Research Advocate, Our guest author this week is Ellie Dehoney, Research!America’s Vice President of Policy and Advocacy. Ten years ago this month, Dr. Francis Collins became the 16th Director of the National Institutes of Health. The Ad Hoc Group for Medical Research, of which Research!America is a member, sent a letter to Dr. Collins congratulating and thanking him for his remarkable service, achievements and impact. Our latest web resource highlights the history, progress, and promise of the groundbreaking research NIH conducts and supports. Funding for NIH and our nation’s other science agencies hinges on timely congressional action, and on you. Don’t wait to advocate. Hard-won...
Dear Research Advocate, Our guest author this week is Jenny Luray, Research!America’s Senior Advisor. Earlier today, the Senate passed -- by a vote of 67-28, the Bipartisan Budget Act of 2019 to raise the budget caps in Fiscal Years 2020 and 2021 and suspend the debt ceiling until July 2021. As Senate Leaders Mitch McConnell (R-KY) and Chuck Schumer (D-NY) worked to round up the votes, Research!America sent a letter of support . The President is expected to sign the bill. Happily, this brings the threat of sequestration and massive discretionary spending cuts to an end. Your advocacy made a difference as you weighed in, time and time again, with your Members of Congress, exhorting them to...
Dear Research Advocate, Our guest author this week is Ellie Dehoney, Research!America’s Vice President of Policy and Advocacy. Some long-awaited, promising news regarding the budget caps: congressional leaders and the White House have agreed in principle on a deal that would raise the discretionary budget caps for Fiscal Years 2020 and 2021 and raise the debt limit sufficiently to avoid another “cliff” for at least two years. There are (as there always seem to be) caveats: the amount by which the caps would increase is not yet public, negotiations continue on such variables as offsets, and we don’t yet know how the deal will fare with other than those members of Congress in leadership roles...
Just three months remain in the current fiscal year, and lawmakers in the House have made significant progress in moving 10 of 12 appropriations bills across the floor. These bills include significant and meaningful funding increases for health research and public health, exciting advocates about the potential to reinvigorate and advance innovation after years of funding cuts, budget stagnation, and making up lost ground. Lawmakers have made clear their support for science in both words and deeds. Unfortunately, making these promises a reality hinges entirely on Congress and the White House’s ability to stave off devastating cuts — 10% across the board — that are scheduled hit defense and...

Pages

Sidebar Quote

Funding research gives all of us a better chance of living a healthier life.
Pam Hirata, heart disease survivor